Oya, K., Nakamura, Y., Watanabe, R., Tanaka, R., Ichimura, Y., Kubota, N., . . . Fujisawa, Y. Eribulin mesylate exerts antitumor effects via CD103. Taylor & Francis Group.
Chicago Style (17th ed.) CitationOya, Kazumasa, et al. Eribulin Mesylate Exerts Antitumor Effects via CD103. Taylor & Francis Group.
MLA (9th ed.) CitationOya, Kazumasa, et al. Eribulin Mesylate Exerts Antitumor Effects via CD103. Taylor & Francis Group.
Warning: These citations may not always be 100% accurate.